the 1mill anually is in addition to what they already have. I can't wait for there first full quarter numbers with the biotech company to see what type of current business they had. I personally see continued releases for new contracts in the near future. This company now has something it didn't really have before and that's a real viable revenue producing business. It may not be quick but this company has a positive future.
Until someone can provide documented evidence to the otherwise, the future looks good.